UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Leukemia, 2009-12, Vol.23 (12), p.2210-2221

2009

Volltextzugriff (PDF)

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

Leukemia, 2011-06, Vol.25 (6), p.1026-1035

2011

Volltextzugriff (PDF)

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial

Leukemia, 2009-07, Vol.23 (7), p.1337-1341

2009

Volltextzugriff (PDF)

Genetic aberrations and survival in plasma cell leukemia

Leukemia, 2008-05, Vol.22 (5), p.1044-1052

2008

Volltextzugriff (PDF)

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

Leukemia, 2010-11, Vol.24 (11), p.1934-1939

2010

Volltextzugriff (PDF)

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

Leukemia, 2013-12, Vol.27 (12), p.2357-2365

2013

Volltextzugriff (PDF)

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

Leukemia, 2007-03, Vol.21 (3), p.529-534

2007

Volltextzugriff (PDF)

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

Leukemia, 2006-11, Vol.20 (11), p.2034-2040

2006

Volltextzugriff (PDF)

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations

Leukemia, 2006-05, Vol.20 (5), p.807-813

2006

Volltextzugriff (PDF)

Characterization of MYC Translocations in Multiple Myeloma Cell Lines

Journal of the National Cancer Institute. Monographs, 2008-07, Vol.2008 (39), p.25-31

2008

Volltextzugriff (PDF)

Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?

Blood cancer journal (New York), 2016-01, Vol.6 (1), p.e384-e384

2016

Volltextzugriff (PDF)

Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

Leukemia, 2018-03, Vol.32 (3), p.719-728

2018

Volltextzugriff (PDF)

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

Nature genetics, 1997-07, Vol.16 (3), p.260-264

1997

Volltextzugriff (PDF)

Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

Blood, 1998-01, Vol.91 (1), p.3-21

1998

Volltextzugriff (PDF)

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma

Leukemia, 2010-04, Vol.24 (4), p.833-842

2010

Volltextzugriff (PDF)

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

Leukemia, 2014-08, Vol.28 (8), p.1725-1735

2014

Volltextzugriff (PDF)

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

Leukemia, 2014-02, Vol.28 (8), p.1725-1735

2014

Volltextzugriff (PDF)

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.201-205

2014

Volltextzugriff (PDF)

Degree of focal immunoglobulin heavy chain locus deletion as a measure of B-cell tumor purity

Leukemia, 2013-10, Vol.27 (10), p.2067-2068

2013

Volltextzugriff (PDF)

Advances in the pathogenesis and diagnosis of multiple myeloma

International journal of laboratory hematology, 2015-05, Vol.37 (S1), p.108-114

2015

Volltextzugriff (PDF)

Multiple myeloma: evolving genetic events and host interactions

Nature reviews. Cancer, 2002-03, Vol.2 (3), p.175-187

2002

Volltextzugriff (PDF)

Targeting vasculogenesis to prevent progression in multiple myeloma

Leukemia, 2016-05, Vol.30 (5), p.1103-1115

2016

Volltextzugriff (PDF)

Genetic events in the pathogenesis of multiple myeloma

Best practice & research. Clinical haematology, 2007-12, Vol.20 (4), p.571-596

2007

Volltextzugriff (PDF)

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VKMYC model of multiple myeloma

Haematologica (Roma), 2015-06, Vol.100 (6), p.834-841

2015

Volltextzugriff (PDF)

Chromosome translocations in multiple myeloma

Oncogene, 2001-09, Vol.20 (40), p.5611-5622

2001

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(186)

Publikationsform

Sprache

Englisch
(211)

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Life Sciences & Biomedicine
(128)
Humans
(126)
Hematology
(91)
Oncology
(74)
Multiple Myeloma - Genetics
(72)
Biological And Medical Sciences
(54)
Multiple Myeloma
(54)
Medical Sciences
(52)
Multiple Myeloma - Pathology
(45)
Cancer Research
(37)
Immunopathology
(37)
Immunodeficiencies. Immunoglobulinopathies
(36)
Immunoglobulinopathies
(36)
Multiple Myeloma - Drug Therapy
(36)
Animals
(35)
Female
(33)
Mice
(33)
Male
(31)
Hematologic And Hematopoietic Diseases
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(60)
Leukemia
(35)
Blood Cancer Journal
(12)
Journal Of Clinical Oncology
(10)
Cancer Research
(7)
Cancer Cell
(6)
Current Topics In Microbiology And Immunology
(6)
Clinical Lymphoma & Myeloma
(5)
The Journal Of Immunology
(5)
Blood Cancer Discovery
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial

Genetic aberrations and survival in plasma cell leukemia

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations

Characterization of MYC Translocations in Multiple Myeloma Cell Lines

Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?

Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Degree of focal immunoglobulin heavy chain locus deletion as a measure of B-cell tumor purity

Advances in the pathogenesis and diagnosis of multiple myeloma

Multiple myeloma: evolving genetic events and host interactions

Targeting vasculogenesis to prevent progression in multiple myeloma

Genetic events in the pathogenesis of multiple myeloma

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VKMYC model of multiple myeloma

Chromosome translocations in multiple myeloma

Suchergebnisse filtern